Among the 134 awarded companies run by women is our Warsaw-based MIM Solutions! The WomenTechEU call is targeting innovative European deep-tech companies founded by women. We appreciate receiving this award and would like to express our gratitude to the entire jury for placing their trust in us. About whole initiative and other winners you can […]

If so, then you must attend tomorrow’s PyData Warsaw and listen to the talk of our co-CEO, Piotr Wygocki! Piotr will speak about: ➡️ how we conduct medical projects ➡️ making of EMBRYOAID and FOLLISCAN – our cutting-edge AI software for fertility ➡️ how do we plan to expand in the following months See you there! 🔥 📆 Wednesday, 12th […]

WE REALLY NEED YOUR HELP TODAY! We are in the semi-finals of the Huawei Startup Challenge organised by Huawei Enterprise Polska and Startup Academy Poland. We want to create a better HealthTech market in Poland and win 100k PLN! Now YOU can help us by voting for our project! How to do that?   Go […]

We couldn’t be more proud! In the upcoming weeks, we will participate in Huawei Startup Challenge organised by Huawei Polska and Startup Academy Poland. We want to create a better HealthTech market in Poland and win 100k PLN! Out of 168 Polish startups, only 20 companies were chosen to participate in the semi-finals. Congrats to […]

This weekend we are celebrating! Our product EMBRYOAID has just received CE marking!   What does it mean for us? The mark provides additional assurance for patients, fertility experts and clinics who use EMBRYOAID that it is a trustworthy & reliable system. CE marking confirms that our product conforms to health, safety and environmental standards agreed […]

Welcome to MIM Fertility! We created a brand new LinkedIn profile to show you how AI revolutionises the reproductive medicine sector. On our profile, you will regularly read about: AI for fertility explained in an easy-to-read way What happens in the fertility world? How the same world looks from the perspective of IVF clinics, embryologists, […]

Another fertility centre joins our MIM family! This time we are conquering Central America. We are extremely happy to welcome Dr. Roberto Epifanio M. and The Fertile Group from Panama to the users of EMBRYOAID. Their patients will be one of the first in the world to use #AI-based system for non-invasive embryo analysis. EMBRYOAID […]

Faster and more efficient diagnostics of breast cancer with AI?   UK-based company Digistain has just passed clinical trials and opened their way to market with personalised cancer treatment recommendations. They created a cost-effective test which uses machine learning to rapidly analyse a patient’s biopsy. It has been validated in multiple hospitals in the UK […]

  Multiple FDA clearances for AI-powered products!   The United States Food and Drug Administration is an agency which certifies medical products in the United States, so they can be used by patients and doctors. In November 2022, FDA gave 510(k) clearance to products for diabetes and Parkinson’s disease detection. Such clearance doesn’t require verification […]

Did you know that the global fertility services market is predicted to be worth more than 36 BILLION USD in 2028? According to Bloomberg, the market increase rapidly because of: 1. public health problems – common diseases like obesity or arrhythmia influence the fertility, 2. innovation in IVF technologies like embryoscopes and capsule IVFs, 3. […]

EMBRYOAID added to Polish Map of Innovations in Healthcare!   What is the Map of Innovations?   Created by the Polish Ministry of Health, it’s a map to distinguish the most innovative projects in Poland, transforming the way that healthcare is delivered.   How to be added there?   According to the gov website, the […]

Piotr Sankowski was quoted in an article from Polityka magazine about IVF procedure. For all our followers who do not speak Polish, we translated the text below! To read the original text, check out this link.   In Vitro Ex Machina. How can AI increase the chance of success in fertility treatment?   Translation of […]